Coronary artery disease trials in Japan

In Japan 18 Also abroad 1313

18 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)
Where
Kawasaki, Matsumoto, Shinagawa Ku, Shinjuku-ku, Tsukuba
Age
20 years to 80 years
People
14
Run by
Heartseed Inc.
See details and how to joinNCT07347197
No phaseTaking people
Prevail Global Study
Where
Kamakura, Kitakyushu, Sendai, tabashi City, Yokohama
Age
18 years and over
People
1,205 worldwide
Run by
Medtronic Vascular
See details and how to joinNCT06535854
No phaseTaking people
Product Surveillance Registry
Where
Ageo, Bunkyo-ku, Chiba, Fukui, Fukuoka, Gifu, Hamamatsu, Hidaka, Hirosaki, Hiroshima, Kagoshima, Kamakura, Kawasaki, Kitakyushu, Kofu, Koshigaya, Kumamoto, Kyoto, Minato-ku, Mitaka, Nagoya, Niigata, Nishinomiya, Okayama, Osaka, Ōsaka-sayama, Ōta-ku, Sakai, Sapporo, Shinagawa-ku, Shizuoka, Suita, Tokyo, Toyoake, Urasoe, Yokohama, Yonago
People
100,000 worldwide
Run by
Medtronic
See details and how to joinNCT01524276
No phaseTaking people
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Where
Kochi, Mitaka, Sagamihara, Sapporo
Age
18 years and over
People
1,616 worldwide
Run by
Boston Scientific Corporation
See details and how to joinNCT06959524
Phase 2Taking people
Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
Where
Kamakura, Kasugai, Matsubara, Matsudo
Age
18 years to 80 years
People
180 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07830719 · EU 2026-525974-21-00
No phaseTaking people
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Where
Fukuoka, Mitaka, Osaka
Age
18 years and over
People
2,000 worldwide
Run by
Stephen Nicholls
See details and how to joinNCT05325034
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Hashima-gun, Higashiosaka-shi, Hiroshima, Hokkaido, Ibaraki, Ichinomiya-shi, Inashiki-gun, Kagoshima, Kamakura-shi, Kanazawa, Kitakyushu-shi, Kurume, Kurume-shi, Kusatsu-shi, Kyoto, Maebashi, Matsubara-shi, Nagaoka-Shi, Nagoya, Ogaki-Shi, Ōmihachiman, Oyama-shi, Sakaimachi, Sapporo, Shinjuku-Ku, Takasaki-Shi, Tsukuba, Ube-shi, Urayasu-shi, Yamagata, Yokohama, Yonago-shi
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
Phase 3Taking people
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
Where
Bunkyo Ku, Chikushino-shi, Kamakura, Kitakyushu, Sagamihara
Age
18 years and over
People
300 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07102628
No phaseTaking people
Randomization of Single vs Multiple Arterial Grafts
Where
Saitama
Age
18 years to 70 years
People
4,300 worldwide
Run by
Weill Medical College of Cornell University
See details and how to joinNCT03217006
No phaseTaking people
Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery Disease
Where
Tokyo, Tsuchiura
Age
20 years and over
People
960 worldwide
Run by
Seung-Jung Park
See details and how to joinNCT05829889
No phaseTaking people
Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease
Where
Tsuchiura
Age
20 years and over
People
1,500 worldwide
Run by
Duk-Woo Park, MD
See details and how to joinNCT05831085
Phase 2Taking people
Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo CABG
Where
Osaka
Age
18 years to 80 years
People
50
Run by
Rohto Pharmaceutical Co., Ltd.
See details and how to joinNCT07192211
No phaseTaking people
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Where
Bunkyo-ku, Saitama
Age
18 years and over
People
2,300 worldwide
Run by
Weill Medical College of Cornell University
See details and how to joinNCT04124120
No phaseTaking people
Thrombus Aspiration and Pathology and OCT Study
Where
Toyoake
Age
20 years and over
People
200
Run by
Fujita Health University
See details and how to joinNCT07151976
No phaseTaking people
REASSURE-NIRS Registry
Where
Miyazaki, Suita
Age
20 years to 95 years
People
2,000
Run by
National Cerebral and Cardiovascular Center, Japan
See details and how to joinNCT04864171
No phaseTaking people
Japanese Coronary Intervention Using Drug Eluting and Perfusion Therapy for Left Main Disease (JDEPTH-LM Registry)
Where
Bunkyo, Chiba, Edogawa City, Fuchū, Fukuoka, Gifu, Hakodate, Ichinomiya, Kamakura, Kanazawa, Katsushika-ku, Kitakyushu, Kochi, Kumamoto, Kurashiki, Maebashi, Matsudo, Matsumoto, Matsuyama, Morioka, Sagamihara, Sapporo, Shinagawa, Shinjuku, Toyoake, Tsuchiura, Tsukuba, Urasoe, Urayasu, Wakayama, Yokosuka
Age
18 years and over
People
280
Run by
TCROSS Co., Ltd.
See details and how to joinNCT06436092
Phase 4Taking people
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
Where
Kyoto
Age
20 years and over
People
2,890
Run by
Takeshi Morimoto
See details and how to joinNCT05347069
No phaseTaking people
Comparison of Optical Coherence Tomography-derived Minimal Lumen Area, Invasive Fractional Flow Reserve and FFRCT
Where
Ageo, Gifu, Nagano, Osaka, Saitama, Sapporo
Age
18 years and over
People
104 worldwide
Run by
Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT03820492